Hemophilia Treatment Market: Double-Digit Growth Expected to Reach $26.9 Billion by 2031 | CAGR of 7.5%
Hemophilia Treatment Market Report
WILMINGTON, DELAWARE, UNITED STATES, May 7, 2024 /EINPresswire.com/ -- Hemophilia treatment market size was valued at $12.8 billion in 2021, and is estimated to reach $26.9 billion by 2031, growing at a CAGR of 7.5% from 2022 to 2031. Hemophilia is a bleeding disorder that slows the blood clotting process. People with this condition experience prolonged bleeding or oozing following an injury, surgery, or having a tooth pulled. In severe cases of hemophilia, continuous bleeding occurs after minor trauma or even when there is no obvious injury. Serious complications in the joints, muscles, brain, or other internal organs can result from bleeding. Milder forms of hemophilia do not necessarily involve spontaneous bleeding, and the condition may not become apparent until abnormal bleeding occurs following surgery or a serious injury. The primary treatment for severe hemophilia involves replacing the clotting factor needed through a tube in a vein.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Novo Nordisk A/S, Grifols, S.A, CSL Ltd. (CSL Behring), Pfizer Inc., octapharma ag, Swedish Orphan Biovitrum AB, F. Hoffmann-La Roche AG, Medexus Pharmaceuticals Inc., Bayer AG, Takeda Pharmaceuticals Company ltd
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/301
On the basis of type, the hemophilia treatment market is categorized as hemophilia A and hemophilia B. The hemophilia A segment was dominant in 2021 and is expected to remain dominant during the forecast period, owing to the rise in incidence of hemophilia A and increased use of factor VIII. Hemophilia A is also projected to exhibit the fastest market growth during the forecast period, owing to technological advancements in treatment of hemophilia and product approval by regulating authorities.
On the basis of drug therapy, the recombinant coagulation factor concentrates therapy segment was dominant in 2021 and is expected to remain dominant during the forecast period, owing to increase in the number of recombinant technology products available for the treatment. Moreover, non-factor replacement therapy is projected to exhibit the fastest growth during hemophilia treatment market forecast period, owing to increase in target population and rise in R&D activities on the treatment therapies.
Europe was the highest revenue contributor in the 2021 and is expected to continue the same during the forecast period. This was attributed to the research activities for hemophilia treatment, which are soaring in Europe, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of hemophilia due to increase in awareness regarding the disease. Asia-Pacific is projected to register the highest CAGR of 8.3% during the forecast period to the hemophilia treatment market share, owing to increase in incidence of population suffering from hemophilia. In addition, increase in healthcare expenditure offers a lucrative opportunity for the hemophilia treatment industry growth.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/301
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2023?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
๐๐๐๐๐๐- ๐ ๐๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐๐ข๐๐ซ๐๐ซ๐ฒ (๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐๐ฆ๐๐ง๐, ๐ฌ๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐ฉ๐ซ๐ข๐๐ข๐ง๐ ๐ฆ๐จ๐๐๐ฅ) ๐๐๐๐๐ซ๐๐ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐๐ญ ๐๐ง ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ ๐ฅ๐ข๐๐ซ๐๐ซ๐ฒ ๐จ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ญ ๐๐ง๐ฒ ๐ญ๐ข๐ฆ๐ ๐๐ซ๐จ๐ฆ ๐๐ง๐ฒ ๐๐๐ฏ๐ข๐๐ ๐๐ง๐ ๐๐ง๐ฒ๐ฐ๐ก๐๐ซ๐. ๐
๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ, ๐๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค: https://www.alliedmarketresearch.com/library-access
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Hemophilia Treatment Market: https://www.alliedmarketresearch.com/hemophilia-treatment-market
Artificial Retina Market: https://www.alliedmarketresearch.com/artificial-retina-market-A10878
Intrauterine Devices Market: https://www.alliedmarketresearch.com/intrauterine-devices-market-A10999
France Ultrasound Guided Infertility Diagnosis and Treatment Market: https://www.alliedmarketresearch.com/france-ultrasound-infertility-diagnosis-and-treatment-market-A15402
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.